Pharmacokinetics of the anticonvulsant drug clonazepam evaluated from single oral and intravenous doses and by repeated oral administration
- PMID: 1233263
- DOI: 10.1007/BF00614012
Pharmacokinetics of the anticonvulsant drug clonazepam evaluated from single oral and intravenous doses and by repeated oral administration
Abstract
Eight healthy volunteers were given single i.v. and oral doses of clonazepam (2 mg). The disposition curves after i.v. administration showed a biexponential decline and the data were applied to a two-compartment open model. The volume of distribution ((Vd)beta) ranged between 1.5 and 4.4 l/kg and the plasma half-life (t1/2) between 19 and 60 hours. Absorption after oral administration was fast, with peak plasma concentrations within 4 hours in all subjects. Five of the subjects received repeated oral doses of clonazepam 0.5 mg bid for 15 days. The plasma level during steady state (estimated as Cmin within the dose interval) could be predicted from the constants A, B, alpha and beta obtained in the single dose study with a coefficient of variation of 6%. The plasma half-lives after cessation of the subchronic dosing were of the same magnitude as after single doses.
Similar articles
-
Pharmacokinetics of clonazepam in the dog.Arch Int Pharmacodyn Ther. 1984 Apr;268(2):180-93. Arch Int Pharmacodyn Ther. 1984. PMID: 6732363
-
Determination of flunitrazepam, desmethylflunitrazepam and clonazepam in plasma by gas liquid chromatography with an internal standard.Arzneimittelforschung. 1977 Feb;27(2):338-42. Arzneimittelforschung. 1977. PMID: 16619
-
Determination of clonazepam ("Rivotril" or "Ro 5-4023") in plasma by gas chromatography using an internal standard.Eur J Toxicol Environ Hyg. 1976 Jul-Aug;9(4):213-25. Eur J Toxicol Environ Hyg. 1976. PMID: 976330
-
Comparative single-dose pharmacokinetics of clonazepam following intravenous, intramuscular and oral administration to healthy volunteers.Eur Neurol. 2003;49(3):173-7. doi: 10.1159/000069089. Eur Neurol. 2003. PMID: 12646763 Clinical Trial.
-
Clinical pharmacokinetics of anticonvulsants.Clin Pharmacokinet. 1976;1(3):161-88. doi: 10.2165/00003088-197601030-00001. Clin Pharmacokinet. 1976. PMID: 797496 Review.
Cited by
-
Multiple peaking phenomena in pharmacokinetic disposition.Clin Pharmacokinet. 2010 Jun;49(6):351-77. doi: 10.2165/11319320-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20481648 Review.
-
Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring.Korean J Physiol Pharmacol. 2011 Apr;15(2):67-81. doi: 10.4196/kjpp.2011.15.2.67. Epub 2011 Apr 30. Korean J Physiol Pharmacol. 2011. PMID: 21660146 Free PMC article.
-
Clonazepam: a review of its pharmacological properties and therapeutic efficacy in epilepsy.Drugs. 1976 Nov;12(5):321-61. doi: 10.2165/00003495-197612050-00001. Drugs. 1976. PMID: 976134
-
Comparative pharmacokinetics of benzodiazepines in dog and man.J Pharmacokinet Biopharm. 1982 Aug;10(4):411-26. doi: 10.1007/BF01065172. J Pharmacokinet Biopharm. 1982. PMID: 6130139
-
An explorative approach to understanding individual differences in driving performance and neurocognition in long-term benzodiazepine users.Hum Psychopharmacol. 2021 Jul;36(4):e2778. doi: 10.1002/hup.2778. Epub 2021 Feb 6. Hum Psychopharmacol. 2021. PMID: 33547849 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources